Future Therapy of Cholangiocarcinoma.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 28229079)

Published in Visc Med on November 18, 2016

Authors

Ruben R Plentz¹, Michael Bitzer¹, Tim Greten², Silvio Nadalin³, Arndt Vogel⁴

Author Affiliations

1: Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.
2: Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
3: Department of Visceral and Transplantation Surgery, University Hospital Tübingen, Tübingen, Germany.
4: Department of Gastroenterology, Hepatology and Endocrinology, Hanover Medical School, Hanover, Germany.

Articles cited by this ↗

Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol (2012) 3.56

Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol (2011) 2.10

Articles by these authors ⇆

The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation. Virchows Arch (2020) 1.39